Without these hubs, the body’s anti-cancer immune response, especially during immunotherapy treatment, may be weaker than previously imagined. The research shows how the specific cells in the lymph ...
Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, chemotherapy, and immunotherapy. But a new discovery may change the way ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as ...
13hon MSN
Cancer cells' stress shield cracked by compound that binds in one place, inhibits in another
Cancer cells are pretty bold and clever—they hijack cellular survival and healing processes in order to fuel their growth, spread throughout the body, and ensure their own survival. The unfolded ...
A bacterial molecule enhances chemotherapy. Its synthetic form could inspire new cancer drugs. An international group of researchers, led by teams at the MRC (LMS), Imperial College London, and the ...
The emergence of drug resistance remains one of the greatest challenges in effective cancer therapy. Despite advances in targeted treatments and ...
The field of oncology research is increasingly focusing on understanding the tumor microenvironment (TME), particularly its implications for drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback